You are here

COVID-19

E.U. planning to Curb Covid Vaccine Exports for 6 Weeks

BRUSSELS — The European Union is finalizing emergency legislation that will give it broad powers to curb exports for the next six weeks of Covid-19 vaccines manufactured in the bloc, a sharp escalation in its response to supply shortages at home that have created a political maelstrom amid a rising third wave on the continent.

Problem, Solution, SitRep, or ?: 

How Detroit chefs are working with organizations to help feed those in need

It's been just over a year since Michigan's restaurants were forced to close indoor dining for the first time.

In that time many chefs pivoted from their restaurants to working with nonprofit groups on a new task: feeding their increasingly hungry communities.

The pandemic has exacerbated food insecurity across the country. In Detroit, it was already 39% before the pandemic.

"Once the pandemic hit, of course, that number heightened dramatically," chef Ederique Goudia tells All Things Considered. "Now we have our next door neighbors, our parents, our sisters, our friends who are now food insecure as well."

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Webnar on COVID-19 Testing strategies, Wednesday, March 24, 11:AM ET--Johns Hopkins Center for Health Security

Webinar Series: Lessons Learned from Organizations Implementing Testing Strategies COVID-19 Testing Toolkit Webinar Series: Lessons from Ginkgo Bioworks and Concentric by Ginkgo

 

Wednesday, March 24 at 11am ET

Join the Johns Hopkins Center for Health Security in the launch of their new informational webinar series on COVID-19 testing strategies and best practices from selected organizational leaders. This webinar series will be hosted as part of the Center’s new COVID-19 Testing Toolkit which aims to provide essential information for all organizations seeking to engage in COVID-19 testing. 

Meeting / Event Tags: 
Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

U.S. health officials and an oversight board accused AstraZeneca of presenting potentially misleading information

Federal health officials and an independent oversight board accused AstraZeneca of presenting the world with potentially misleading information about the effectiveness of the company’s Covid-19 vaccine, an extraordinary blow to the credibility of a company whose product has been seen as critical to the global fight against the pandemic.

In a two-page letter to AstraZeneca and federal authorities on Monday, an independent panel of medical experts that was helping oversee the vaccine’s clinical trial in the United States said the company had essentially cherry-picked data that was “most favorable for the study as opposed to the most recent and most complete.”

Problem, Solution, SitRep, or ?: 

Some poorer nations could wait years to get vaccinations--Kenya example

...

It was three months after rich countries began vaccinating health workers, but Kenyans like the nurse, Stella Githaiga, had been left behind: Employed in the country’s largest public hospital, she caught the coronavirus on an outreach trip to remote communities in February, she believes, sidelining her even as Kenya struggles with a vicious third surge of infections.

Ms. Githaiga and her colleagues are victims of one of the most galling inequities in a pandemic that has exposed so many: Across the global south, health workers are being sickened and killed by a virus from which doctors and nurses in many rich countries are now largely protected.

That is just the most visible cost of a rich-poor divide that has deepened in the second year of the pandemic. Of the vaccine doses given globally, roughly three-quarters have gone to only 10 countries. At least 30 countries have not yet injected a single person.

Problem, Solution, SitRep, or ?: 

Pages

Subscribe to COVID-19
howdy folks
Page loaded in 1.294 seconds.